Latest revenue
$144.8M
as of 2026-03-31
Latest net income
$-160.8M
as of 2026-03-31
Net margin
-111.1%
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Special Industry Machinery, NEC (15 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 7, 2026.
Community sentiment
Where do you think AZTA is heading?
Price · 5Y
Market data
Price feed temporarily unavailable for AZTA.
5-year trend
What this company does
Item 1. Business Overview We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market. This led us to develop and provide solutions for automated ultra-cold storage. Since then, we have expanded our life sciences offerings through internal investments and through a series of acquisitions. We support our customers from research and clinical development to commercialization with our sample management and automated storage…
AI summary unavailable — showing raw filing excerpt
Generated from AZTA's filing dated 2025-12-04
Key risks
Item 1A. Risk Factors Factors That May Affect Future Results Investing in Azenta common stock involves a high degree of risk. You should carefully consider the following risks and uncertainties, together with the other information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes included under Part II, Item 8, “Financial Statements and Supplementary Data,” and Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” before investing in our common stock. The risks described below are material to our business and could materially adversely affect our business, financial condition, or…
AI summary unavailable — showing raw filing excerpt
Generated from AZTA's filing dated 2025-12-04
Profitability
Gross margin
45.5%
13.4%Operating margin
-4.5%
85.2%Net margin
-9.4%
62.6%Return on equity
-3.2%
66.2%Return on assets
-2.7%
65.5%Leverage
Debt / equity
0.17×
11.8%Long-term debt / equity
0.04×
Debt / assets
14.2%
10.2%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $144.8M | +1.0% | $-160.8M | -297.5% | -111.1% |
Q4 2025 2025-12-31 | $148.6M | +0.8% | $-15.4M | -40.4% | -10.4% |
Q3 2025 2025-09-30 | $159.1M | -32.0% | $48.5M | +949.1% | 30.5% |
Q2 2025 2025-06-30 | $143.9M | -0.2% | $-52.8M | -702.3% | -36.7% |
Q1 2025 2025-03-31 | $143.3M | +5.1% | $-40.5M | +70.4% | -28.2% |
Q4 2024 2024-12-31 | $147.4M | +4.0% | $-11.0M | +30.1% | -7.5% |
Q3 2024 2024-09-30 | $234.0M | — | $-5.7M | — | -2.4% |
Q2 2024 2024-06-30 | $144.3M | -13.0% | $-6.6M | -347.8% | -4.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Special Industry Machinery, NEC · SIC 3559
Your notes
Keep private notes on AZTA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$233.7K
Insider selling
$71.2K
Net activity
+$162.5K
Distinct insiders
5
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns AZTA
Institutional value
$563.7M
Total shares held
28.0M
Distinct holders
146
-147 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.7M | $142.1M | -55.2K (-0.8%) | Trimmed |
| 2 | Conestoga Capital Advisors, LLC | 2.8M | $60.1M | +1.5M (+116.1%) | Added |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5M | $51.8M | — | New |
| 4 | DIMENSIONAL FUND ADVISORS LP | 2.1M | $43.5M | -39.1K (-1.9%) | Trimmed |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $38.6M | — | New |
| 6 | Allspring Global Investments Holdings, LLC | 1.6M | $34.2M | +225.9K (+16.3%) | Added |
| 7 | CONGRESS ASSET MANAGEMENT CO | 1.1M | $24.2M | -139.8K (-10.9%) | Trimmed |
| 8 | Stephens Investment Management Group LLC | 1.0M | $21.6M | -48.0K (-4.5%) | Trimmed |
| 9 | FEDERATED HERMES, INC. | 854.4K | $18.1M | +230.7K (+37.0%) | Added |
| 10 | UBS Group AG | 569.1K | $12.0M | +242.4K (+74.2%) | Added |
| 11 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 557.7K | $11.8M | +111.4K (+25.0%) | Added |
| 12 | ROYCE & ASSOCIATES LP | 523.3K | $11.1M | — | New |
| 13 | FIFTH THIRD BANCORP | 285.6K | $6.0M | +284.3K (+21522.4%) | Added |
| 14 | NEW YORK STATE COMMON RETIREMENT FUND | 270.9K | $5.7M | +0 (+0.0%) | No change |
| 15 | VANGUARD FIDUCIARY TRUST CO | 270.6K | $5.7M | — | New |
| 16 | Bank of New York Mellon Corp | 249.3K | $5.3M | -88.1K (-26.1%) | Trimmed |
| 17 | SEI INVESTMENTS CO | 243.4K | $5.1M | +59.8K (+32.5%) | Added |
| 18 | NORDEA INVESTMENT MANAGEMENT AB | 226.9K | $4.6M | -12.0K (-5.0%) | Trimmed |
| 19 | Invesco Ltd. | 213.1K | $4.5M | -19.2K (-8.3%) | Trimmed |
| 20 | PRINCIPAL FINANCIAL GROUP INC | 199.3K | $4.2M | +4.8K (+2.5%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once AZTA's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.